$2.5 Million Awarded to Plaintiff Who Suffered Gynecomastia

By | Pharmaceutical litigation, Risperdal, Uncategorized

risperdal_lawsuit_risperdal_lawsuit_settlements_risperdal_side_effects_risperdal_gynecomastia_risperdal_breast_developmentAt 7 years-old, a boy with autism started taking Risperdal; four years in, the boy experienced dramatic physical changes. He started to grow breasts.

What is Risperdal? And what does it have to do with male breast growth?

Risperdal is an anti-psychotic drug manufactured by Janssen, a unit of Johnson & Johnson. The drug is known to cause male breast growth.

Risperdal activates a hormone called prolactin, which is responsible for breast growth and lactation in women.

A Danger to Children

Children’s bodies are particularly sensitive to prolactin. Janssen knew about the risk of Risperdal male breast growth in children, but did not share this with the U.S. Food and Drug Administration (FDA).

Johnson & Johnson Punished

The family of the autistic boy who used Risperdal filed a lawsuit against Janssen. Their Risperdal lawsuit claimed that Janssen covered up the risk of male breast growth―also called gynecomastia―in children.

At the trial held in a Philadelphia court, the jury agreed with the family’s claim, and awarded them with $2.5 million in compensation.

Our Role Is to Help You

Our team of attorneys is committed to helping anyone who has been injured by defective drugs. Carey Danis & Lowe helps countless families impacted by Risperdal and male breast growth. We are available to guide you through your legal options and compensation eligibility during a free case evaluation.

We Want to Hear from You

Contact Carey Danis & Lowe today. Call us at 800.721.2519, or submit a confidential personal injury claim form.

Risperdal: Pharmaceutical Companies & Off-Label Drug Marketing

By | Pharmaceutical litigation, Risperdal, Uncategorized

risperdal_lawsuit_risperdal_lawsuit_settlements_risperdal_side_effects_risperdal_gynecomastia_risperdal_breast_developmentAs a national law firm that practices defective drug and personal injury litigation, Carey Danis & Lowe has worked on numerous cases where a pharmaceutical company misrepresented a product, and in doing so, ignored patient health and safety.

Even though their products have proven to be harmful in some cases, a recent Washington Post article on off-label drug marketing revealed that pharmaceutical companies often declare a violation of freedom of speech in regards to overly strict marketing regulations.

Johnson & Johnson and Risperdal Off-Label Drug Marketing

Johnson & Johnson conducted a misleading marketing campaign for their anti-psychotic drug, Risperdal. Approved by the U.S. Food and Drug Administration (FDA) to treat adults with schizophrenia, Johnson & Johnson marketed the drug for use in children.

According to the U.S. Department of Justice, Johnson & Johnson, and their subsidiary, Janssen, were aware of the dangers the drug Risperdal posed when used by children. Even so, company representatives marketed the drug to mental health professionals who worked with children.

As a result of their misleading Risperdal marketing campaign, Johnson & Johnson was ordered in 2013 by the U.S. Department of Justice to pay a $2.2 billion fine.

Risperdal Male Breast Growth

When used by children and adolescents, Risperdal has been known to cause male breast growth, also known as gynecomastia, due to the drug triggering the production of the hormone prolactin. For some patients who have suffered from gynecomastia as a Risperdal side effect, they have also dealt with decreased psychological and emotional well being as a result of physical changes.

Carey Danis & Lowe Helps Victims

Carey Danis & Lowe represents patients who have been injured by Risperdal and other defective drugs. Our defective drug lawyers are offering free initial case evaluations, and are available to discuss legal options and compensation eligibility.

If you or someone you love has been injured by Risperdal, contact the St. Louis law firm of Carey Danis & Lowe by phone at 800.721.2519, or complete a personal injury claim form.